Press releases
- Press releases
- Browse
Press releases
Genesis 2010, Westminster, Thursday 9 December is on track to attract a larger than ever attendance to debate new medicines and healthcare products research. More
Two papers on Embil's novel triple-active topical products (Neo-Penotran® Forte and Neo-Penotran® Forte-L) have been accepted for presentation at the 4'th World Conference on Vaginitis, Costa Rica, 10-13 Jan 2004 More
An HIV/AIDS vaccine developed by University of Western Ontario professor Chil-Yong Kang has reached "an important milestone" as it pushes towards the first phase of human trials. More
Unique Low T treatment expected to eliminate the problematic transference side effect More
London UK, 11 April 2012 - Based on its recent analysis of the responsive polymer for bio-medical application market, Frost & Sullivan recognises CIS Pharma with the 2011 European Frost & Sullivan Technology Innovation Award for its unique Cellophil™ bio- More
New Clinical Study results on SULIDIN® 1% Nimesulide LPS gel presented at the 8'th World Congress on Clinical Pharamacology and Therapeutics, Brisbane, Australia, 1-6 August 2004. More
Michael Gamlen will be hosting a live demonstration and launch event at the Institute of Directors, London, on 17th March to unveil the Gamlen Tablet Press. More
Life Science Leadership Series – Oncology
12 May 2011
Clare College, Cambridge
To complement the global biopartnering conferences, share knowledge and engage thought leaders in challenging each other to progress the development of new treat More
12 May 2011
Clare College, Cambridge
To complement the global biopartnering conferences, share knowledge and engage thought leaders in challenging each other to progress the development of new treat More
A flavonoid derived from citrus fruit has shown tremendous promise for preventing weight gain and other signs of metabolic syndrome which can lead to Type 2 Diabetes and increased risk of cardiovascular disease. More
Scientists at Robarts Research Institute, working in collaboration with researchers in Brazil, have used a unique genetically-modified mouse line to reveal a previously unidentified mechanism contributing to heart failure. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jun 2011 - 19 pages - $125
May 2011 - 15 pages - $125
May 2011 - 25 pages - $125
May 2011 - 15 pages - $250
Feb 2011 - 11 pages - $125
May 2011 - 15 pages - $250
Feb 2011 - 16 pages - $125
May 2011 - 25 pages - $125
Mar 2011 - 16 pages - $250
Mar 2008 - $2,500
Your selection
- Industry sector
- Academic/Research del
Browse By
- Industry sector
- Animal health
- Biotech
- Diagnostic
- Drug delivery
- Medical device
- Pharmaceutical
- Therapeutic target
- Accident and Trauma
- Allergy
- Blood and forming organs
- Cardiovascular
- Central Nervous System
- Dermatological
- Endocrinology
- Gastrointestinal
- Genetic disorders
- Genito-urinary
- Hospital and Surgery
- Immune related disorders
- Infectious diseases
- Metabolism
- Musculoskeletal
- Oncology
- Oral Health
- Other therapeutic
- Respiratory
- Sensory organ
- Year
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000
- 1999
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us